Thrombotic diseases, in particular cardiovascular and cerebrovascular thrombotic diseases, have become the top cause of death in the population of China, and their incidence has increased, seriously endangering human health.

China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

April 25, Swiss drugmaker Roche's (ROG.S) first quarter sales rose a better-than-expected 10% on strong U.S. demand for rapid COVID-19 antigen tests and drugs including Ocrevus against multiple sclerosis as well as Hemlibra against haemophilia.

For the three months ending March 31, total revenue was 74,283.49 million CNY compared to 39.53% growth in the year-ago period with the total profit of 35, 813.66 million CNY compared to 76.23% growth over the same period last year.

Existing methods for detecting and diagnosing COVID-19 are either expensive and complex or inaccurate.

Danaher reported on Thursday a 12 percent year-over-year increase in total revenues.

On April 19, Maccura Biotechnology Co., Ltd. released its 2021 annual financial report. The company achieved CNY 3.981 billion revenue in 2021, a year-on-year increase of 7.47%; net profit attributable to shareholders of listed companies was CNY 957 million, a year-on-year increase of 20.49%.

Abbott announced before the market opened on Wednesday that its first quarter Diagnostics business revenues grew 32 percent year over year.

With the help of single-cell sequencing, a team from Boston Children's Hospital, the Broad Institute, Harvard Medical School, and elsewhere has found evidence for enhanced somatic mutation in brain cells from individuals with Alzheimer's disease.

A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate the alpha variant of the SARS-CoV-2 virus from earlier strains in saliva samples.

Diagnostics instrument and reagent developer MicroGem announced on Tuesday that it has obtained Emergency Use Authorization from the US Food and Drug Administration for a rapid point-of-care PCR instrument and COVID test.

On April 19, Mindary (300760.SZ) released its 2021 annual report, showing that in 2021 the company achieved revenue of CNY 25.270 billion, up 20.18%, achieved net profit attributable to the mother company of CNY 8.002 billion, up 20.19%.